Omega Healthcare Investors (NYSE:OHI – Get Free Report) will likely be announcing its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Omega Healthcare Investors to post earnings of $0.5090 per share and revenue of $266.9680 million for the quarter. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Investors may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The company had revenue of $322.95 million for the quarter, compared to analyst estimates of $264.07 million. During the same quarter in the prior year, the business earned $0.75 earnings per share. Omega Healthcare Investors’s revenue was up 16.7% compared to the same quarter last year. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Omega Healthcare Investors Price Performance
Shares of NYSE OHI opened at $51.75 on Monday. The stock has a market cap of $15.41 billion, a P/E ratio of 25.00, a P/E/G ratio of 2.21 and a beta of 0.58. Omega Healthcare Investors has a twelve month low of $38.22 and a twelve month high of $51.92. The stock has a 50 day moving average of $47.49 and a two-hundred day moving average of $46.45. The company has a current ratio of 5.32, a quick ratio of 5.32 and a debt-to-equity ratio of 0.81.
Omega Healthcare Investors Increases Dividend
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. Bank of America reiterated an “underperform” rating and issued a $46.00 price objective (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. Royal Bank Of Canada boosted their target price on shares of Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, May 4th. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $47.00 to $49.00 and gave the stock an “equal weight” rating in a research note on Monday, June 1st. UBS Group set a $47.00 price target on shares of Omega Healthcare Investors in a report on Thursday, June 18th. Finally, Raymond James Financial began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 price objective for the company. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $48.50.
Read Our Latest Analysis on OHI
Institutional Investors Weigh In On Omega Healthcare Investors
Hedge funds have recently modified their holdings of the company. Invesco Ltd. increased its stake in shares of Omega Healthcare Investors by 101.7% in the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock worth $208,775,000 after buying an additional 2,493,877 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Omega Healthcare Investors during the 4th quarter valued at $93,476,000. Daiwa Securities Group Inc. grew its holdings in Omega Healthcare Investors by 84.6% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,058,031 shares of the real estate investment trust’s stock worth $129,110,000 after acquiring an additional 1,401,066 shares in the last quarter. State Street Corp grew its holdings in Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after acquiring an additional 671,473 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of Omega Healthcare Investors by 21.1% in the 2nd quarter. AQR Capital Management LLC now owns 3,464,943 shares of the real estate investment trust’s stock worth $126,263,000 after purchasing an additional 602,826 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Stories
- Five stocks we like better than Omega Healthcare Investors
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
